In silico and in vitro screening of FDA-approved drugs for potential repurposing against tuberculosis
Sridharan Brindha, Jagadish Chandrabose Sundaramurthi, Savariar Vincent, Devadasan Velmurugan, John Joel Gnanadoss
This study screens FDA-approved drugs for tuberculosis repurposing using in silico and in vitro methods, identifying lymecycline and cefpodoxime as active against drug-susceptible and resistant strains.
bioRxiv · Dec 3, 2017 · PreprintBioinformatics